Skip to main content
. 2014 Jan 22;4(1):130202. doi: 10.1098/rsob.130202

Figure 2.

Figure 2.

FlaA and MOMP are required for C. jejuni BgAg binding. (a) NCTC11168 and its ΔflaA mutant derivative were examined for binding to Leb, H-II, H-I and Lea. Binding of 11168ΔflaA was significantly reduced compared with the wild-type (*p < 0.05; **p < 0.01). Error bars: mean of triplicate values ± s.e.m. from three independent experiments. (b) Binding of NCTC11168 to H-II glycoconjugate in the absence of inhibitor (non-treated, NT) or after H-II coated plates were treated with purified NCTC11168 MOMP before the addition of bacteria or after NCTC11168 were pre-incubated with H-II glycoconjugate (H-II). ***significantly reduced compared with non-treated (p < 0.001). Error bars: mean of triplicate values ± s.e.m. from three independent experiments.